Aerospace company tapped for mission for new spacewalk, moonwalk system

in the works

NASA has issued another grant to Collins Aerospace to design the future of spacewalks and moonwalks. Image via NASA

Charlotte, North Carolina-based Collins Aerospace has been selected by NASA to develop a spacewalking system for the astronauts aboard the International Space Station.

The award, which is the second under NASA’s Exploration EVA Services contract, has a base value of $97.2 million, per a Dec. 8 news release from NASA. The company has until January 2024 "to complete a critical design review and demonstrate use of the suit on Earth in a simulated space environment," according to NASA, which will then decide the option to extend the contract for testing to be conducted by April 2026.

NASA’s Johnson Space Center in Houston manages the spacesuit contract. Collins Aerospace has had a presence in Houston for 40 years, and recently cut the ribbon on a $30 million facility near the JSC.

“We look forward to obtaining another much-needed service under our contract,” says Lara Kearney, manager of the Extravehicular Activity and Human Surface Mobility Program at JSC, in the release. “By working with industry, NASA is able to continue its over 22-year legacy of maintaining a presence in low-Earth orbit.”

The current system was designed decades ago and has been used during previous space shuttle and space station missions. Collins Aerospace will work with Houston-based Axiom Space on this project, which was initially announced this summer.

"Both vendors will continue to compete for future task orders which include recurring services for station spacewalks and moonwalks beyond Artemis III," the news release reads.

Axiom Space will outfit our astronauts. Photo courtesy of NASA

Houston tech company lands exclusive spacesuit deal for NASA's mission to moon

suit up

When astronauts make a historic return to the surface of the moon, presumably 2025 or 2026, they’ll don Houston-crafted, life-protecting suits.

Houston-based Axiom Space has landed the rights to create spacesuits and supporting systems for NASA’s Artemis III mission, which will see humans back on our satellite for the first time since the legendary Apollo missions more than 50 years ago.

This award is the first for a competitive spacesuits contract, NASA notes in a press release. NASA tapped Axiom Space for a task order boasting a base value of $228.5 million. As previously reported, Axiom Space was one of two companies NASA pegged for spacesuit and supporting system development.

These new suits are pivotal, as plans for NASA’s Artemis lunar program call for not just lunar orbit, but trips to the lunar south pole and even a crewed outpost on the moon.

Axiom Space will be responsible for the design, development, qualification, certification, and production of its spacesuits and support equipment. Spacesuits will be tested for moonwalks and spacewalks.

This spacesuit contract, which will advance spacewalking capabilities in low-Earth orbit and on the Moon, is managed by the Extravehicular Activity and Human Surface Mobility Program (EHP) at Johnson Space Center.

“NASA is proud to partner with commercial industry on this historic mission that will kickstart the United States building a lasting presence on the surface of the Moon,” said Lara Kearney, manager of NASA’s Extravehicular Activity and Human Surface Mobility program. “What we learn on Artemis III and future missions on and around the Moon will pave the way for missions to Mars. Spacesuits enable us to literally take that next step.”

The first lunar mission since 1972, Artemis will be historic in myriad ways, none of least for seeing the first woman and the first person of color on the moon, as well as a testing ground for eventual Mars missions.

Artemis I is set to launch on September 19, barring any delays.

------

This article originally ran on CultureMap.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

Houston's Ion District to expand with new research and tech space, The Arc

coming soon

Houston's Ion District is set to expand with the addition of a nearly 200,000-square-foot research and technology facility, The Arc at the Ion District.

Rice Real Estate Company and Lincoln Property Company are expected to break ground on the state-of-the-art facility in Q2 2026 with a completion target set for Q1 2028, according to a news release.

Rice University, the new facility's lead tenant, will occupy almost 30,000 square feet of office and lab space in The Arc, which will share a plaza with the Ion and is intended to "extend the district’s success as a hub for innovative ideas and collaboration." Rice research at The Arc will focus on energy, artificial intelligence, data science, robotics and computational engineering, according to the release.

“The Arc will offer Rice the opportunity to deepen its commitment to fostering world-changing innovation by bringing our leading minds and breakthrough discoveries into direct engagement with Houston’s thriving entrepreneurial ecosystem,” Rice President Reginald DesRoches said in the release. “Working side by side with industry experts and actual end users at the Ion District uniquely positions our faculty and students to form partnerships and collaborations that might not be possible elsewhere.”

Developers of the project are targeting LEED Gold certification by incorporating smart building automation and energy-saving features into The Arc's design. Tenants will have the opportunity to lease flexible floor plans ranging from 28,000 to 31,000 square feet with 15-foot-high ceilings. The property will also feature a gym, an amenity lounge, conference and meeting spaces, outdoor plazas, underground parking and on-site retail and dining.

Preleasing has begun for organizations interested in joining Rice in the building.

“The Arc at the Ion District will be more than a building—it will be a catalyst for the partnerships, innovations and discoveries that will define Houston’s future in science and technology,” Ken Jett, president of Rice Real Estate Company, added in the release. “By expanding our urban innovation ecosystem, The Arc will attract leading organizations and talent to Houston, further strengthening our city’s position as a hub for scientific and entrepreneurial progress.”

Intel Corp. and Rice University sign research access agreement

innovation access

Rice University’s Office of Technology Transfer has signed a subscription agreement with California-based Intel Corp., giving the global company access to Rice’s research portfolio and the opportunity to license select patented innovations.

“By partnering with Intel, we are creating opportunities for our research to make a tangible impact in the technology sector,” Patricia Stepp, assistant vice president for technology transfer, said in a news release.

Intel will pay Rice an annual subscription fee to secure the option to evaluate specified Rice-patented technologies, according to the agreement. If Intel chooses to exercise its option rights, it can obtain a license for each selected technology at a fee.

Rice has been a hub for innovation and technology with initiatives like the Rice Biotech Launch Pad, an accelerator focused on expediting the translation of the university’s health and medical technology; RBL LLC, a biotech venture studio in the Texas Medical Center’s Helix Park dedicated to commercializing lifesaving medical technologies from the Launch Pad; and Rice Nexus, an AI-focused "innovation factory" at the Ion.

The university has also inked partnerships with other tech giants in recent months. Rice's OpenStax, a provider of affordable instructional technologies and one of the world’s largest publishers of open educational resources, partnered with Microsoft this summer. Google Public Sector has also teamed up with Rice to launch the Rice AI Venture Accelerator, or RAVA.

“This agreement exemplifies Rice University’s dedication to fostering innovation and accelerating the commercialization of groundbreaking research,” Stepp added in the news release.

Houston team develops low-cost device to treat infants with life-threatening birth defect

infant innovation

A team of engineers and pediatric surgeons led by Rice University’s Rice360 Institute for Global Health Technologies has developed a cost-effective treatment for infants born with gastroschisis, a congenital condition in which intestines and other organs are developed outside of the body.

The condition can be life-threatening in economically disadvantaged regions without access to equipment.

The Rice-developed device, known as SimpleSilo, is “simple, low-cost and locally manufacturable,” according to the university. It consists of a saline bag, oxygen tubing and a commercially available heat sealer, while mimicking the function of commercial silo bags, which are used in high-income countries to protect exposed organs and gently return them into the abdominal cavity gradually.

Generally, a single-use bag can cost between $200 and $300. The alternatives that exist lack structure and require surgical sewing. This is where the SimpleSilo comes in.

“We focused on keeping the design as simple and functional as possible, while still being affordable,” Vanshika Jhonsa said in a news release. “Our hope is that health care providers around the world can adapt the SimpleSilo to their local supplies and specific needs.”

The study was published in the Journal of Pediatric Surgery, and Jhonsa, its first author, also won the 2023 American Pediatric Surgical Association Innovation Award for the project. She is a recent Rice alumna and is currently a medical student at UTHealth Houston.

Bindi Naik-Mathuria, a pediatric surgeon at UTMB Health, served as the corresponding author of the study. Rice undergraduates Shreya Jindal and Shriya Shah, along with Mary Seifu Tirfie, a current Rice360 Global Health Fellow, also worked on the project.

In laboratory tests, the device demonstrated a fluid leakage rate of just 0.02 milliliters per hour, which is comparable to commercial silo bags, and it withstood repeated disinfection while maintaining its structure. In a simulated in vitro test using cow intestines and a mock abdominal wall, SimpleSilo achieved a 50 percent reduction of the intestines into the simulated cavity over three days, also matching the performance of commercial silo bags. The team plans to conduct a formal clinical trial in East Africa.

“Gastroschisis has one of the biggest survival gaps from high-resource settings to low-resource settings, but it doesn’t have to be this way,” Meaghan Bond, lecturer and senior design engineer at Rice360, added in the news release. “We believe the SimpleSilo can help close the survival gap by making treatment accessible and affordable, even in resource-limited settings.”
View All Listings